Home › Overweight › North Carolina › Raleigh
Overweight clinical trials in Raleigh, NC
5 studies for Overweight are looking for participants at sites in and around Raleigh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RecruitingPhase 3
- Accellacare of Raleigh, Raleigh
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Accellacare of Raleigh, Raleigh
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 3
- AURORA-1 Clinical Site, Raleigh
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Raleigh
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Accellacare of Raleigh, Raleigh
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL27 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Atlanta, GA20 studies
- Dallas, TX20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Raleigh
- Heart Failure7 studies
- Type 2 Diabetes6 studies
- Obesity6 studies
- Coronary Artery Disease6 studies
- Macular Degeneration6 studies
- Stroke5 studies
- Endometrial Cancer5 studies
- Cardiovascular Disease5 studies
- Atherosclerosis5 studies
- Diabetes4 studies
- Macular Edema4 studies
- Non-Small Cell Lung Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.